Consolidation therapy with high-dose cytosine arabinoside: experiences of a prospective study in acute myeloid leukemia

Haematol Blood Transfus. 1990:33:254-60. doi: 10.1007/978-3-642-74643-7_46.
No abstract available

Publication types

  • Clinical Trial
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cytarabine / administration & dosage*
  • Cytarabine / adverse effects
  • Daunorubicin / administration & dosage
  • Etoposide / administration & dosage
  • Germany, West / epidemiology
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / mortality
  • Leukemia, Myelomonocytic, Acute / drug therapy*
  • Leukemia, Myelomonocytic, Acute / mortality
  • Life Tables
  • Middle Aged
  • Multicenter Studies as Topic
  • Prospective Studies
  • Survival Rate

Substances

  • Cytarabine
  • Etoposide
  • Daunorubicin

Supplementary concepts

  • DAV regimen